CD314/NKG2D/KLRK1 Target & Gene Products-cDNA ORF clones/siRNA/antibody/protein

Explore CD314/NKG2D/KLRK1 gene products and cross-species research data at TarMart platform. Discover comprehensive biological information, expression tools, and therapeutic insights for Homo sapiens (human), Cynomolgus monkeys, rodents (mouse/rat), canines, felines, bovines, and equines. Your premier destination for multi-species gene research solutions
Target sublocation: Transmembrane Protein.
Natural killer (NK) cells are lymphocytes that can mediate lysis of certain tumor cells and virus-infected cells without previous activation. They can also regulate specific humoral and cell-mediated immunity. NK cells preferentially express several calcium-dependent (C-type) lectins, which have been implicated in the regulation of NK cell function. The NKG2 gene family is located within the NK complex, a region that contains several C-type lectin genes preferentially expressed in NK cells. This gene encodes a member of the NKG2 family. The encoded transmembrane protein is characterized by a type II membrane orientation (has an extracellular C terminus) and the presence of a C-type lectin domain. It binds to a diverse family of ligands that include MHC class I chain-related A and B proteins and UL-16 binding proteins, where ligand-receptor interactions can result in the activation of NK and T cells. The surface expression of these ligands is important for the recognition of stressed cells by the immune system, and thus this protein and its ligands are therapeutic targets for the treatment of immune diseases and cancers. Read-through transcription exists between this gene and the upstream KLRC4 (killer cell lectin-like receptor subfamily C, member 4) family member in the same cluster. [provided by RefSeq, Dec 2010]

Target ID GM-T35289
Target Name CD314/NKG2D/KLRK1
Gene Group ldentifer
(Target Gene ID in Homo species)
22914
Gene ID 100053963 (Equus caballus), 22914 (Homo sapiens), 24934 (Rattus norvegicus), 27007 (Mus musculus)
404058 (Bos taurus), 611355 (Canis lupus familiaris)
Target Alternative Names KLRK1,Klrk1,KLR,CD314,NKG2D,NKG2-D,D12S2489E,Nkrp2,Nkg2d,D6H12S2489E,KLRC
Uniprot Accession P26718,O70215,O54709
Uniprot Entry Name
Protein Sub-location Transmembrane Protein
Category Therapeutics Target, Immuno-oncology Target, INN Index
Disease cancer
Disease from KEGG Natural killer cell mediated cytotoxicity, Malaria
Gene Ensembl ENSECAG00000017267, ENSG00000213809, ENSMUSG00000030149, ENSBTAG00000004917, ENSCAFG00845026278
Target Classification Checkpoint-Immuno Oncology, Tumor-associated antigen (TAA)


Pre-made viral vector of CD314/NKG2D/KLRK1 cDNA Clones/ORF Plasmid

Cat No.Product NameNMIDGeneIDSpeciesTypeMarkerFusion TagPromoterDetail
pGMLP000859Human KLRK1/CD314/D12S2489E Lentivirus plasmidNM_00736022914HumanLentivirus plasmidZsGreen3xflag (C-Terminal)CMVDetail
vGMLP000859Human KLRK1/CD314/D12S2489E Lentivirus particleNM_00736022914HumanLentivirus particleZsGreen3xflag (C-Terminal)CMVDetail


CD314/NKG2D/KLRK1 siRNA/miRNA/oligo for RNA interfence (RNAi)

Cat No.Product NameGeneIDSpeciesGradeDetail
pGMoligo22914Pre-made Human KLRK1/KLR/CD314 siRNA oligo Duplex22914HumanIn-vitro grade; in-vivo gradeDetail
pGMoligo24934Pre-made Rat Klrk1/NKG2D/Nkrp2 siRNA oligo Duplex24934RatIn-vitro grade; in-vivo gradeDetail
pGMoligo27007Pre-made Mouse Klrk1/Nkg2d/NKG2-D siRNA oligo Duplex27007MouseIn-vitro grade; in-vivo gradeDetail
pGMoligo611355Pre-made Dog/Canine KLRK1 siRNA oligo Duplex611355Dog/CanineIn-vitro grade; in-vivo gradeDetail
pGMoligo404058Pre-made Bovines/Cattle KLRK1/KLRC/NKG2-D siRNA oligo Duplex404058Bovines/CattleIn-vitro grade; in-vivo gradeDetail
pGMoligo100053963Pre-made Equine/Horse KLRK1 siRNA oligo Duplex100053963Equine/HorseIn-vitro grade; in-vivo gradeDetail


CD314/NKG2D/KLRK1 antibody/GMab

Cat No.SpeciesAntibody NameFormatClassified by tagDetail
GM-Tg-hg-T35289-AbHumanAnti-Human CD314/NKG2D/KLRK1 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail
GM-Tg-rg-T35289-AbRatAnti-Rat CD314/NKG2D/KLRK1 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail
GM-Tg-mg-T35289-AbMouseAnti-Mouse CD314/NKG2D/KLRK1 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail
GM-Tg-cang-T35289-AbDog/CanineAnti-Dog/Canine CD314/NKG2D/KLRK1 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail
GM-Tg-bovg-T35289-AbBovines/CattleAnti-Bovines/Cattle CD314/NKG2D/KLRK1 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail
GM-Tg-equg-T35289-AbEquine/HorseAnti-Equine/Horse CD314/NKG2D/KLRK1 monoclonal antibodymabFACS/Biofunctional Antibody, Therapeutics Target antibodyDetail


CD314/NKG2D/KLRK1 VLP (virus-like particle)

Cat No.SpeciesAntigen NameExpression PlatformDetail
GM-Tg-hg-T35289-AgHumanHuman CD314/NKG2D/KLRK1 VLP (virus-like particle)HEK293Products Developing
GM-Tg-rg-T35289-AgRatRat CD314/NKG2D/KLRK1 VLP (virus-like particle)HEK293Products Developing
GM-Tg-mg-T35289-AgMouseMouse CD314/NKG2D/KLRK1 VLP (virus-like particle)HEK293Products Developing
GM-Tg-cang-T35289-AgDog/CanineDog/Canine CD314/NKG2D/KLRK1 VLP (virus-like particle)HEK293Products Developing
GM-Tg-bovg-T35289-AgBovines/CattleBovines/Cattle CD314/NKG2D/KLRK1 VLP (virus-like particle)HEK293Products Developing
GM-Tg-equg-T35289-AgEquine/HorseEquine/Horse CD314/NKG2D/KLRK1 VLP (virus-like particle)HEK293Products Developing